JP2012528858A5 - - Google Patents

Download PDF

Info

Publication number
JP2012528858A5
JP2012528858A5 JP2012513932A JP2012513932A JP2012528858A5 JP 2012528858 A5 JP2012528858 A5 JP 2012528858A5 JP 2012513932 A JP2012513932 A JP 2012513932A JP 2012513932 A JP2012513932 A JP 2012513932A JP 2012528858 A5 JP2012528858 A5 JP 2012528858A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
branched
compound
unbranched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012513932A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012528858A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/001596 external-priority patent/WO2010141074A2/en
Publication of JP2012528858A publication Critical patent/JP2012528858A/ja
Publication of JP2012528858A5 publication Critical patent/JP2012528858A5/ja
Pending legal-status Critical Current

Links

JP2012513932A 2009-06-01 2010-06-01 O−GlcNAc転移酵素阻害剤およびその使用 Pending JP2012528858A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21751409P 2009-06-01 2009-06-01
US61/217,514 2009-06-01
PCT/US2010/001596 WO2010141074A2 (en) 2009-06-01 2010-06-01 O-glcnac transferase inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2012528858A JP2012528858A (ja) 2012-11-15
JP2012528858A5 true JP2012528858A5 (cg-RX-API-DMAC7.html) 2014-05-22

Family

ID=43298360

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012513932A Pending JP2012528858A (ja) 2009-06-01 2010-06-01 O−GlcNAc転移酵素阻害剤およびその使用

Country Status (4)

Country Link
US (1) US8957075B2 (cg-RX-API-DMAC7.html)
EP (1) EP2438046A4 (cg-RX-API-DMAC7.html)
JP (1) JP2012528858A (cg-RX-API-DMAC7.html)
WO (1) WO2010141074A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008156676A1 (en) 2007-06-15 2008-12-24 President And Fellows Of Harvard College Methods and compositions for detecting and modulating o-glycosylation
JP2012528858A (ja) 2009-06-01 2012-11-15 プレジデント アンド フェロウズ オブ ハーバード カレッジ O−GlcNAc転移酵素阻害剤およびその使用
WO2013006758A1 (en) 2011-07-06 2013-01-10 President And Fellows Of Harvard College Diphosphate mimetics and uses thereof
WO2013027168A1 (en) * 2011-08-22 2013-02-28 Pfizer Inc. Novel heterocyclic compounds as bromodomain inhibitors
CN104470515B (zh) 2012-05-03 2016-12-07 圣路易斯药学院 用于增加神经营养肽的组合物和方法
US20170166558A1 (en) * 2014-07-01 2017-06-15 President And Fellows Of Harvard College O-glcnac transferase (ogt) inhibitors and uses thereof
CN107903185B (zh) * 2017-11-08 2020-05-26 四川大学 新型eEF2K抑制剂的制备及应用
WO2020047251A1 (en) * 2018-08-29 2020-03-05 President And Fellows Of Harvard College O-glcnac transferase inhibitors and uses thereof
TW202130643A (zh) * 2019-10-29 2021-08-16 美商百健Ma公司 螺環o-醣蛋白-2-乙醯胺基-2-去氧-3-d-葡萄哌喃糖苷酶抑制劑
DE102019129527A1 (de) 2019-10-31 2021-05-06 Forschungszentrum Jülich GmbH Inhibitoren für Bromodomänen
KR102571503B1 (ko) * 2020-09-14 2023-08-28 부산대학교 산학협력단 암질환 예방 또는 치료용 조성물

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
CH572305A5 (en) 1972-02-04 1976-02-13 Vnii Chim Sredstv Zaschity Benzoxazoline-2-thione-3-carboxylic acid esters - with phytopathogenic fungicidal activity for use on cucumber, potato, wheat, maize, rice, etc.
DE2210419A1 (de) 1972-02-08 1973-09-06 Vnii Fitopatologii Benzoxazolintion-2-karbon-3-saeureester und verfahren zu deren herstellung
GB1330611A (en) 1972-02-17 1973-09-19 Vnii Khim Sredstv Zaschily Ras Fungicides for green plants
CH570990A5 (en) 1972-03-06 1975-12-31 Vnii Chim Sredstv Zaschity Benzoxazoline-2-thione derivs - with antifungal activity
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4420486A (en) 1981-01-22 1983-12-13 Hokko Chemical Industry Co., Ltd. Benzoxazolone derivatives, processes for preparation thereof and compositions containing them
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4886499A (en) 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US6352694B1 (en) 1994-06-03 2002-03-05 Genetics Institute, Inc. Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5407686A (en) 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US6100048A (en) 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
WO1995024176A1 (en) 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
WO1995024929A2 (en) 1994-03-15 1995-09-21 Brown University Research Foundation Polymeric gene delivery system
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US6413740B1 (en) 1995-12-15 2002-07-02 Regeneron Pharmaceuticals, Inc. Tyrosine kinase receptors and ligands
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
US20030170864A1 (en) 2000-05-30 2003-09-11 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6593456B1 (en) 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
US6388063B1 (en) 1997-06-18 2002-05-14 Sugen, Inc. Diagnosis and treatment of SAD related disorders
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
CA2320625A1 (en) 1998-02-09 1999-08-12 Human Genome Sciences, Inc. 45 human secreted proteins
US7166475B2 (en) 1999-02-26 2007-01-23 Cyclacel Ltd. Compositions and methods for monitoring the modification state of a pair of polypeptides
US6410255B1 (en) 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays
EP1263938A1 (en) 2000-02-11 2002-12-11 Henrik Clausen Udp-galactose: beta-d-galactose-r 4-alpha-d-galactosyltransferase, alpha4gal-t1
AU2001249310A1 (en) 2000-03-21 2001-10-03 Uab Research Foundation Prevention and/or treatment of diabetes mellitus by pharmacologically inhibitingpancreatic beta-cell o-linked protin glycosylation and/or pancreatic beta-cell p135 o-glycosylation
US20030186948A1 (en) 2000-03-21 2003-10-02 Jeffrey Kudlow O-linked N-acetylglucosamine pathway in the pathogenesis of neurodegeneration and diabetes
US6916636B2 (en) 2000-08-26 2005-07-12 Degussa Ag Nucleotide sequences which code for the oxyR gene
MXPA03002918A (es) 2000-10-02 2004-04-20 Arizeke Pharmaceuticals Inc Composiciones y metodos para el transporte de agentes biologicamente activos a traves de barreras celulares.
US7696163B2 (en) 2001-10-10 2010-04-13 Novo Nordisk A/S Erythropoietin: remodeling and glycoconjugation of erythropoietin
WO2004042075A2 (en) 2002-11-08 2004-05-21 Glycozym Aps Inactivated ga1 - nac - transferases, methods for inhibitors of such transferases and their use
UA80453C2 (en) 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
EP1431397B1 (en) 2002-12-19 2007-11-21 F. Hoffmann-La Roche Ag Method for measuring UDP-GlcNAc
EP1431396A1 (en) 2002-12-19 2004-06-23 F. Hoffmann-La Roche Ag Method for measuring glucosamine-6-phosphate
US7067529B2 (en) 2003-05-19 2006-06-27 Hoffmann-La Roche Inc. Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
JP2007508338A (ja) 2003-10-16 2007-04-05 エフ.ホフマン−ラ ロシュ アーゲー グルタミンフルクトース−6−リン酸アミドトランスフェラーゼ(gfat)インヒビター
ES2560657T3 (es) 2004-01-08 2016-02-22 Ratiopharm Gmbh Glicosilación con unión en O de péptidos G-CSF
WO2007120638A2 (en) * 2006-04-12 2007-10-25 President And Fellows Of Harvard College Methods and compositions for modulating glycosylation
WO2008156676A1 (en) 2007-06-15 2008-12-24 President And Fellows Of Harvard College Methods and compositions for detecting and modulating o-glycosylation
US20110105477A1 (en) 2007-09-14 2011-05-05 The Regents Of The University Of Michigan Compositions and methods relating to hiv protease inhibition
CA2709784A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
WO2009086952A2 (en) 2008-01-07 2009-07-16 Projech Science To Technology, S.L. Compositions for the treatment of degenerative articular diseases
JP2012528858A (ja) 2009-06-01 2012-11-15 プレジデント アンド フェロウズ オブ ハーバード カレッジ O−GlcNAc転移酵素阻害剤およびその使用
WO2013006758A1 (en) 2011-07-06 2013-01-10 President And Fellows Of Harvard College Diphosphate mimetics and uses thereof

Similar Documents

Publication Publication Date Title
JP2012528858A5 (cg-RX-API-DMAC7.html)
JP2008525416A5 (cg-RX-API-DMAC7.html)
Küçükgüzel et al. Synthesis and biological activity of 4-thiazolidinones, thiosemicarbazides derived from diflunisal hydrazide
IL258732A (en) Salts and their benzene and polymorphs
JP2009533410A5 (cg-RX-API-DMAC7.html)
JP2009526864A5 (cg-RX-API-DMAC7.html)
JP2010521417A5 (cg-RX-API-DMAC7.html)
JP2009530399A5 (cg-RX-API-DMAC7.html)
JP2010077141A5 (cg-RX-API-DMAC7.html)
JP2008512490A5 (cg-RX-API-DMAC7.html)
JP2008514732A5 (cg-RX-API-DMAC7.html)
JP2009527501A5 (cg-RX-API-DMAC7.html)
JP2013528180A5 (cg-RX-API-DMAC7.html)
JP2004516314A5 (cg-RX-API-DMAC7.html)
JP2016512531A5 (cg-RX-API-DMAC7.html)
JP2010504343A5 (cg-RX-API-DMAC7.html)
JP2009530398A5 (cg-RX-API-DMAC7.html)
CA2855759C (en) Tricyclic compounds, compositions comprising them and uses thereof
WO2014148949A1 (ru) Алкил 2-{[(2r,3s,5r)-5-(4-амино-2-оксо-2н-пиримидин-1-ил)-3-гидрокси-тетрагидро-фуран-2-илметокси]-фенокси-фосфориламино}-пропионаты, нуклеозидные ингибиторы рнк-полимеразы hcv ns5b, способы их получения и применения
JP2010502730A5 (cg-RX-API-DMAC7.html)
JP2006508970A5 (cg-RX-API-DMAC7.html)
JP2010501478A5 (cg-RX-API-DMAC7.html)
JP2014500861A5 (cg-RX-API-DMAC7.html)
JP2010090149A5 (cg-RX-API-DMAC7.html)
TWI526446B (zh) 喜樹鹼的新穎20(s)-磺基脒衍生物及其抗腫瘤劑的用途